Table 2.

BMT outcomes.

Outcomes	Time after BMT	Outcome estimate (95% CI) unless otherwise specified
OS	1 year	74 (61–83)
	3 years	72 (59–81)
RFS	1 year	72 (60–82)
	3 years	44 (29–59)
GRFS	1 year	55 (42–66)
	3 years	30 (17–43)
NRM	1 year	21 (12–32)
	3 years	23 (14–34)
Relapse	1 year	5 (1–12)
	3 years	31 (17–47)
Acute GVHD, all grades	3 months	36 (25–48)
	6 months	48 (36–60)
Acute GVHD, Grades 3–4	3 months	10 (4–19)
	6 months	13 (6–22)
Chronic GVHD, all grades	1 year	22 (13–33)
	2 years	29 (17–41)
Chronic GVHD, extensive grade	1 and 2 years	8 (3–16)
Days to neutrophil engraftment (N = 65), median (range)		20 (14–70)
Days to platelet engraftment (N = 56), median (range)		34 (15–224)

BMT blood or marrow transplantation, CI 95% confidence intervals, GRFS GVHD-free relapse-free survival, GVHD graft versus host disease, NRM non-relapse mortality, OS overall survival, RFS relapse free survival